Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | 9,15k | 0,00 | Derivative Exercise and Retained Stock | - | 33,80k | 37,12% |
| 2026-05-26 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | 94,96k | 0,00 | Derivative Exercise and Retained Stock | - | 231,40k | 69,60% |
| 2026-05-26 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | 18,99k | 0,00 | Derivative Exercise and Retained Stock | - | 32,17k | 144,12% |
| 2026-05-26 | Mr. Brett A. WallExecutive Officer | 26,91k | 0,00 | Derivative Exercise and Retained Stock | - | 48,34k | 125,56% |
| 2026-05-26 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | 15,20k | 0,00 | Derivative Exercise and Retained Stock | - | 17,24k | 744,12% |
| 2026-05-26 | Ms. Denise L. BlomquistVP, Global Controller & CAO | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 6,81k | 33,61% |
| 2026-05-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | -35,00 | 2,80k | Sale to Issuer | 80,00 | 24,55k | -0,14% |
| 2026-04-28 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -318,00 | 26,04k | Sale to Issuer | 81,90 | 5,09k | -5,88% |
| 2026-04-28 | Mr. Kendall J. PowellIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 24,04k | -0,85% |
| 2026-04-28 | Dr. Elizabeth G. NabelIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 17,47k | -1,17% |
| 2026-04-28 | Mr. Kevin E. LoftonIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 8,03k | -2,51% |
| 2026-04-28 | Mr. Gregory Peter LewisIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 3,64k | -5,38% |
| 2026-04-28 | Mr. Randall J. HoganIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 46,89k | -0,44% |
| 2026-04-28 | Mr. Scott C. DonnellyIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 21,57k | -0,95% |
| 2026-04-28 | Ms. Lidia L. FonsecaIndependent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 5,53k | -3,61% |
| 2026-04-28 | Mr. Craig ArnoldLead Independent Director | -207,00 | 16,95k | Sale to Issuer | 81,90 | 40,07k | -0,51% |
| 2026-03-03 | Mr. Thierry PietonExec. VP & CFO | -2,98k | 287,81k | Sale to Issuer | 96,71 | 6,96k | -29,96% |
| 2026-02-19 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -50,88k | 346,52k | Derivative Exercise and Sale | 80,00 - 97,86 | 1,77k | - |
| 2026-02-19 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -1,65k | 161,18k | Verkauf | 97,77 - 97,83 | 1,77k | -48,19% |
| 2026-02-20 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -340,00 | 0,00 | Other Disposition | - | 4,31k | -7,31% |
| 2026-01-29 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -148,00 | 14,95k | Sale to Issuer | 101,00 | 4,65k | -3,08% |
| 2025-12-15 | Mr. Brett A. WallExecutive Officer | -439,00 | 43,84k | Sale to Issuer | 99,87 | 20,90k | -2,06% |
| 2025-12-15 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -1,37k | 136,92k | Sale to Issuer | 99,87 | 12,40k | -9,96% |
| 2025-12-15 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | -1,56k | 156,20k | Sale to Issuer | 99,87 | 134,70k | -1,15% |
| 2025-12-05 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -1,70k | 172,51k | Sale to Issuer | 101,36 | 3,18k | -34,86% |
| 2025-11-20 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -170,00 | 0,00 | Other Disposition | - | 4,31k | -3,79% |
| 2025-11-19 | Mr. Gregory L. SmithInsider | -30,00k | 3,06M | Verkauf | 101,93 - 102,08 | 36,23k | -45,30% |
| 2025-09-03 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -8,61k | 788,05k | Verkauf | 91,58 - 91,59 | 2,42k | -78,06% |
| 2025-08-22 | Mr. William R. JellisonIndependent Director | 5,00k | 462,75k | Kauf | 92,37 - 92,73 | 5,00k | - |
| 2025-08-20 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -1,05k | 98,07k | Sale to Issuer | 93,22 | 13,52k | -7,22% |
| 2025-08-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | 1,23k | 6,55k | Derivative Exercise and Retained Stock | 78,00 | 24,02k | 5,41% |
| 2025-08-01 | Mr. Matthew R. WalterSVP of HR, IT and Global Communications & Corporate Marketing | -1,91k | 102,08k | Derivative Exercise and Sale | 78,00 - 89,34 | 24,02k | - |
| 2025-08-01 | Mr. Brett A. WallExecutive Officer | 3,66k | 0,00 | Derivative Exercise and Retained Stock | - | 21,09k | 20,96% |
| 2025-08-01 | Mr. Brett A. WallExecutive Officer | -11,59k | 1,04M | Derivative Exercise and Sale | 89,34 | 21,09k | - |
| 2025-08-01 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | 21,15k | 218,56k | Derivative Exercise and Retained Stock | 78,00 | 135,43k | 18,51% |
| 2025-08-01 | Mr. Geoffrey Straub MarthaChairman of the Board & CEO | -77,18k | 3,95M | Derivative Exercise and Sale | 78,00 - 89,34 | 135,43k | - |
| 2025-08-01 | Mr. Gregory L. SmithInsider | 4,21k | 0,00 | Derivative Exercise and Retained Stock | - | 25,59k | 19,72% |
| 2025-08-01 | Mr. Gregory L. SmithInsider | -7,11k | 635,56k | Derivative Exercise and Sale | 89,34 | 25,59k | - |
| 2025-08-01 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | 1,90k | 20,44k | Derivative Exercise and Retained Stock | 78,00 | 14,57k | 14,98% |
| 2025-08-01 | Mr. Michael MarinaroExec. VP and President of Medical Surgical Portfolio & Americas | -7,76k | 470,15k | Derivative Exercise and Sale | 78,00 - 89,34 | 14,57k | - |
| 2025-08-01 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | 2,90k | 0,00 | Derivative Exercise and Retained Stock | - | 11,02k | 35,73% |
| 2025-08-01 | Mr. Harry KiilExec. VP & President of Cardiovascular Portfolio | -7,56k | 674,96k | Derivative Exercise and Sale | 89,34 | 11,02k | - |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | 460,00 | 16,69k | Derivative Exercise and Retained Stock | 78,00 | 4,38k | 11,73% |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -58,00 | 5,18k | Derivative Exercise and Sale | 89,34 | 4,38k | - |
| 2025-08-01 | Ms. Denise L. BlomquistVP, Global Controller & CAO | -457,00 | 40,83k | Sale to Issuer | 89,34 | 4,38k | -9,45% |
| 2025-07-31 | Mr. Gregory L. SmithInsider | -1,63k | 147,09k | Sale to Issuer | 90,24 | 21,37k | -7,09% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
